Cargando…

No Time to Die: How Kidney Cancer Evades Cell Death

The understanding of the pathogenesis of renal cell carcinoma led to the development of targeted therapies, which dramatically changed the overall survival rate. Nonetheless, despite innovative lines of therapy accessible to patients, the prognosis remains severe in most cases. Kidney cancer rarely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganini, Carlo, Montanaro, Manuela, Scimeca, Manuel, Palmieri, Giampiero, Anemona, Lucia, Concetti, Livia, Melino, Gerry, Bove, Pierluigi, Amelio, Ivano, Candi, Eleonora, Mauriello, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181490/ https://www.ncbi.nlm.nih.gov/pubmed/35682876 http://dx.doi.org/10.3390/ijms23116198

Ejemplares similares

Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer
por: Ganini, Carlo, et al.
Publicado: (2021)

Cancer predictive studies
por: Amelio, Ivano, et al.
Publicado: (2020)

ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer
por: Montanaro, Manuela, et al.
Publicado: (2023)

Liquid biopsies and cancer omics
por: Amelio, Ivano, et al.
Publicado: (2020)

The role of noncoding RNAs in epithelial cancer
por: Agostini, Massimiliano, et al.
Publicado: (2020)

Global mapping of cancers: The Cancer Genome Atlas and beyond
por: Ganini, Carlo, et al.
Publicado: (2021)

p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms
por: Pitolli, Consuelo, et al.
Publicado: (2019)

Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy
por: Scimeca, Manuel, et al.
Publicado: (2023)

The biochemistry of cell death: Cell Death: Apoptosis and Other Means to an End, Second Edition by Douglas R. Green, St. Jude Children’s Research Hospital, Cold Spring Harbor Laboratory Press, New York, 2018
por: Zampieri, Carlotta, et al.
Publicado: (2020)

New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP
por: Marchetti, Paolo, et al.
Publicado: (2021)

Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death
por: Scimeca, Manuel, et al.
Publicado: (2021)

Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies
por: Yang, Xue, et al.
Publicado: (2023)

ZNF185 is a p53 target gene following DNA damage
por: Smirnov, Artem, et al.
Publicado: (2018)

Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End‐Stage Renal Disease
por: Mauriello, Alessandro, et al.
Publicado: (2015)

p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer
por: Zampieri, Carlotta, et al.
Publicado: (2022)

ZNF185 is a p63 target gene critical for epidermal differentiation and squamous cell carcinoma development
por: Smirnov, Artem, et al.
Publicado: (2018)

Cell death pathologies: targeting death pathways and the immune system for cancer therapy
por: Pentimalli, Francesca, et al.
Publicado: (2018)

Hypertension in kidney transplantation is associated with an early renal nerve sprouting
por: Mauriello, Alessandro, et al.
Publicado: (2017)

Macrophage polarization and metabolism in atherosclerosis
por: Hou, Pengbo, et al.
Publicado: (2023)

Persistence of SARS-CoV-2 Viral RNA in Nasopharyngeal Swabs after Death: An Observational Study
por: Servadei, Francesca, et al.
Publicado: (2021)

The “Sharp” blade against HIF-mediated metastasis
por: Amelio, Ivano, et al.
Publicado: (2012)

Damage limitation
por: Amelio, Ivano, et al.
Publicado: (2016)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation
por: Nicolai, Sara, et al.
Publicado: (2019)

p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
por: Smirnov, Artem, et al.
Publicado: (2019)

p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer
por: Cappello, Angela, et al.
Publicado: (2023)

NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
por: Mammarella, Eleonora, et al.
Publicado: (2021)

p73 Alternative Splicing: Exploring a Biological Role for the C-Terminal Isoforms
por: Vikhreva, Polina, et al.
Publicado: (2018)

Exploiting tumour addiction with a serine and glycine-free diet
por: Amelio, Ivano, et al.
Publicado: (2017)

Commensal microbes and p53 in cancer progression
por: Celardo, Ivana, et al.
Publicado: (2020)

ΔNp63 promotes IGF1 signalling through IRS1 in squamous cell carcinoma
por: Frezza, Valentina, et al.
Publicado: (2018)

ΔNp63-Senataxin circuit controls keratinocyte differentiation by promoting the transcriptional termination of epidermal genes
por: Gatti, Veronica, et al.
Publicado: (2022)

Bispecific antibodies come to the aid of cancer immunotherapy
por: Amelio, Ivano, et al.
Publicado: (2021)

Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021)

Gene expression in organoids: an expanding horizon
por: Smirnov, Artem, et al.
Publicado: (2023)

The Paradox Effect of Calcification in Carotid Atherosclerosis: Microcalcification Is Correlated with Plaque Instability
por: Montanaro, Manuela, et al.
Publicado: (2021)

Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia
por: Mauriello, Alessandro, et al.
Publicado: (2021)

p63 the guardian of human reproduction
por: Amelio, Ivano, et al.
Publicado: (2012)

The hypoxic tumour microenvironment
por: Petrova, Varvara, et al.
Publicado: (2018)

Serine and glycine metabolism in cancer()
por: Amelio, Ivano, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oa09q9s3hhiqr64causrv3pkgk